Metropolis Healthcare Limited

Metropolis Healthcare Limited (METROPOLIS) is a small-cap Healthcare company valued at ₹10,936 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move

Metropolis Healthcare Limited last traded at ₹549.9, sharply up 5.14% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing revenue of ₹450 crore and net profit of ₹57 crore, up 16.6% and 25.7% respectively from the same quarter a year earlier. On 2026-03-20, the company announced a bonus issue of 1:4. On 2026-05-19, the company declared a dividend of ₹1.00 per share.

Financial performance

The company's business has improved, with annual revenue rising 23.7% and annual net profit growing 30.9%. The latest quarter saw revenue increase 16.6% and net profit rise 25.7% compared to the same quarter a year earlier. Net profit margin expanded 0.6 percentage points to 11.6%, while return on equity remained stable at 12.6%.

Valuation multiples

The stock trades at 59.8 times earnings, a premium to the Healthcare median of 32.0, 8.24 times book value. It yields 0.8%.

Things to watch

The stock is 12.9% below its 52-week high. Promoter shares pledged account for 1.18% of promoter holding. Domestic institutional holding decreased by 0.67 percentage points in the quarter.

Where it stands

The company has delivered strong growth in both revenue and net profit over the past year and quarter, with margins improving. The stock is currently trading below its 52-week high, and promoter shares are pledged. The most significant movement was in domestic institutional holding, which fell by 0.67 percentage points.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.